Patent ID: 8021320

Claim:
A therapeutic agent delivery system for delivering a therapeutic agent through an artificial channel which passes through a chest wall, parietal membrane, visceral membrane and into a lung of a patient there being a seal between the visceral membrane and parietal membrane surrounding the artificial channel, the therapeutic agent delivery system comprising: a pneumostoma management device which includes, a tube adapted to be placed through the artificial channel such that a distal end of the tube is positioned within the lung of the patient, a flange connected to a proximal end of the tube adapted to secure the pneumostoma management device to the chest wall of the patient and secure the tube within the artificial channel, and an aperture at the proximal end of the tube; and a therapeutic agent delivery device including; a container adapted to receive at least one dose of the therapeutic agent; a self-sealing dispensing port that is adapted to communicate with the aperture of the pneumostoma management device; and an actuator that can release the therapeutic agent; whereby, with the pneumostoma management device secured in a pneumostoma and the self-sealing dispensing port coupled to the aperture of the pneumostoma management device, operation of the actuator releases the therapeutic agent through the self-sealing dispensing port via the aperture and tube of the pneumostoma management device through the chest wall and into the lung of the patient.